Fred Ettehadieh

Fred Ettehadieh is a procurement professional dedicated to advancing mission-critical acquisitions across diverse federal domains, with a focus on ensuring efficient and compliant contract execution. Though specific agency details are not disclosed, his work centers on sourcing specialized goods and services that support public health, scientific research, and operational support functions. He manages a broad spectrum of procurements under FAR Part 12 and Part 15, often utilizing indefinite-delivery/indefinite-quantity (IDIQ) vehicles and simplified acquisition procedures to meet urgent operational needs while maintaining rigorous compliance standards. His contracting patterns reflect a balanced approach to vendor engagement, with no single contractor dominating his portfolio, indicating a deliberate strategy to foster competition and avoid single-source dependency. He routinely engages with merchant wholesalers, professional services firms, and niche technology providers, cultivating relationships with both established vendors and emerging small businesses. His procurement approach emphasizes transparency, market research, and performance-based outcomes, ensuring value and accountability in every acquisition cycle. A strong advocate for small business participation, Ettehadieh consistently allocates approximately one-third of his contracting activity to Total Small Business Set-Asides under FAR 19.5, demonstrating a measurable commitment to socioeconomic goals. While no 8(a), HUBZone, or SDVOSB preferences are evident in current data, his reliance on broad small business set-asides signals a strategic intent to expand opportunity across the small business ecosystem without narrowing eligibility criteria. His primary procurement focus lies in five key NAICS categories: medical and dental equipment wholesaling, animal production services, general support services, professional scientific and technical consulting, and biotechnology research and development. This multidisciplinary portfolio underscores his expertise in procuring high-complexity goods and services ranging from laboratory supplies and veterinary products to R&D contracts for emerging biotech innovations, reflecting a nuanced understanding of both commercial and federal regulatory landscapes.